A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report

Biological monoclonal antibodies such as infliximab have significantly remodeled inflammatory bowel disease's treatment course. Despite multiple side effects reported with infliximab, this medication has shown to be robust and practical. There is a paucity of cases reporting venous thromboembol...

Descripción completa

Detalles Bibliográficos
Autores principales: Bala, Areeg, Barbarawi, Mahmoud, Sidahmed, Shima, Kanugula, Ashok Kumar, Bachuwa, Ghassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478590/
https://www.ncbi.nlm.nih.gov/pubmed/32923216
http://dx.doi.org/10.7759/cureus.9615
_version_ 1783580086390226944
author Bala, Areeg
Barbarawi, Mahmoud
Sidahmed, Shima
Kanugula, Ashok Kumar
Bachuwa, Ghassan
author_facet Bala, Areeg
Barbarawi, Mahmoud
Sidahmed, Shima
Kanugula, Ashok Kumar
Bachuwa, Ghassan
author_sort Bala, Areeg
collection PubMed
description Biological monoclonal antibodies such as infliximab have significantly remodeled inflammatory bowel disease's treatment course. Despite multiple side effects reported with infliximab, this medication has shown to be robust and practical. There is a paucity of cases reporting venous thromboembolism (VTE) occurrence during the treatment with infliximab. Although such an association's exact mechanism is still not precise, we should be aware of the drug thromboembolic aptitude. Close attention should be given to patients who started infliximab infusion for any symptoms of pulmonary embolism or deep vein thrombosis.
format Online
Article
Text
id pubmed-7478590
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-74785902020-09-11 A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report Bala, Areeg Barbarawi, Mahmoud Sidahmed, Shima Kanugula, Ashok Kumar Bachuwa, Ghassan Cureus Internal Medicine Biological monoclonal antibodies such as infliximab have significantly remodeled inflammatory bowel disease's treatment course. Despite multiple side effects reported with infliximab, this medication has shown to be robust and practical. There is a paucity of cases reporting venous thromboembolism (VTE) occurrence during the treatment with infliximab. Although such an association's exact mechanism is still not precise, we should be aware of the drug thromboembolic aptitude. Close attention should be given to patients who started infliximab infusion for any symptoms of pulmonary embolism or deep vein thrombosis. Cureus 2020-08-08 /pmc/articles/PMC7478590/ /pubmed/32923216 http://dx.doi.org/10.7759/cureus.9615 Text en Copyright © 2020, Bala et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Bala, Areeg
Barbarawi, Mahmoud
Sidahmed, Shima
Kanugula, Ashok Kumar
Bachuwa, Ghassan
A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report
title A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report
title_full A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report
title_fullStr A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report
title_full_unstemmed A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report
title_short A Cause-Effect Relationship of Infliximab and Pulmonary Embolism: A Case Report
title_sort cause-effect relationship of infliximab and pulmonary embolism: a case report
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478590/
https://www.ncbi.nlm.nih.gov/pubmed/32923216
http://dx.doi.org/10.7759/cureus.9615
work_keys_str_mv AT balaareeg acauseeffectrelationshipofinfliximabandpulmonaryembolismacasereport
AT barbarawimahmoud acauseeffectrelationshipofinfliximabandpulmonaryembolismacasereport
AT sidahmedshima acauseeffectrelationshipofinfliximabandpulmonaryembolismacasereport
AT kanugulaashokkumar acauseeffectrelationshipofinfliximabandpulmonaryembolismacasereport
AT bachuwaghassan acauseeffectrelationshipofinfliximabandpulmonaryembolismacasereport
AT balaareeg causeeffectrelationshipofinfliximabandpulmonaryembolismacasereport
AT barbarawimahmoud causeeffectrelationshipofinfliximabandpulmonaryembolismacasereport
AT sidahmedshima causeeffectrelationshipofinfliximabandpulmonaryembolismacasereport
AT kanugulaashokkumar causeeffectrelationshipofinfliximabandpulmonaryembolismacasereport
AT bachuwaghassan causeeffectrelationshipofinfliximabandpulmonaryembolismacasereport

Ejemplares similares